Broxuridine

DB12028InvestigationalSmall molecule

Broxuridine has been used in trials studying the treatment of Leukemia, Stage I Prostate Cancer, Stage IIB Prostate Cancer, and Stage IIA Prostate Cancer.

Chemical structure of Broxuridine
Formula / weight
C9H11BrN2O5 · 307.098 g/mol (avg)
Also known as
Bromodeoxyuridine
Code names
NSC-38297

Resolves to

Compound
UNIIG34N38R2N1CAS59-14-3ChEMBLCHEMBL222280ChEBI472552PubChem6035
Structure
InChIKeyWOVKYSAHUYNSMH-RRKCRQDMSA-NSMILESOC[C@H]1O[C@H](C[C@@H]1O)N1C=C(Br)C(=O)NC1=O
Targets
Q9QNF7TK

What you can answer from here — as of July 11, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Broxuridine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In